Combined immunotherapy and chemotherapy with tuftsin plus cyclophosphamide in the treatment of non-small-cell carcinoma of the lung.
Warner
E
E
Department of Clinical Oncology, Hadassah University Hospital, Jerusalem, Israel.
Sulkes
A
A
Gez
E
E
Uziely
B
B
Ben-Baruch
N
N
Ben-Yosef
R
R
Biran
S
S
Catane
R
R
D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000628:therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008175:Lung Neoplasms / Q000188:drug therapy / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D014405:Tuftsin / Q000627:therapeutic use*
D003520:Cyclophosphamide; D014405:Tuftsin